Indivior Pharmaceuticals, Inc. (E7P)
Munich
Closed
Jul 3, 2026
Day's Range
35.6052 wk Range
12.60Overview - E7P - Indivior Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
156.00M
P/E (Trailing)
‪21.19‬
Price / Book
‪-30.98‬
EV / EBITDA
‪0.50‬
Profitability
Gross Margin
‪87.38%‬
Profit Margin
‪80.14%‬
Operating Margin
‪22.92%‬
Return on Assets
‪17.47%‬
Return on Equity
‪-212.12%‬
Ownership
Shares Outstanding
122.00M
Price stats
50-Day Avg
‪31.28‬
200-Day Avg
‪23.29‬
Dividends
Frequency
Annual
Peers - E7P - Indivior Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
- E7PMunichIndivior Pharmaceuticals, Inc.+62.36%52-week change21.19P/E (Trailing)‪80.14%‬Profit Margin
- 3KFMunichAuxly Cannabis Group Inc.+94.35%52-week change4.53P/E (Trailing)‪57.26%‬Profit Margin
- HLSMunichAIC Mines Limited+64.23%52-week change—P/E (Trailing)—Profit Margin
- PA8MunichPaion AG+81.23%52-week change-0.81P/E (Trailing)‪94.10%‬Profit Margin
- I76MunichIronwood Pharmaceuticals Inc.+69.73%52-week change24.67P/E (Trailing)—Profit Margin
- 6CWMunichCharlottes Web Holdings Inc.+69.64%52-week change-1.47P/E (Trailing)‪43.48%‬Profit Margin
- 29TAMunichTherapeuticsMD, Inc.+49.73%52-week change-37.80P/E (Trailing)—Profit Margin
Profile Summary - E7P - Indivior Pharmaceuticals, Inc.
About
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on medications for opioid use disorder and related addiction treatment needs. Its portfolio includes prescription therapies such as Sublocade, Suboxone, and Subutex, which are used in clinical settings to support recovery and ongoing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
